CIK 0001707502 · Non-accelerated filer<br>Smaller reporting company
Solid Biosciences Inc.
Sign in to watch- Ticker
- SLDB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 900943402
- Phone
- 617-337-4680
- Business address
- 500 RUTHERFORD AVENUE, 3RD FLOOR, CHARLESTOWN, MA, 02129
- Former names
- Solid Biosciences, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $24,582
- in 1 filing, $25K under 10b5-1 plans
Net −$24,582. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-02 | Ganot Ilan Director | Option exercise · Restricted Stock Units | −1,553 | 0 | ||
| 2024-04-03 | SMITH IAN F Director | Option exercise | +3,256 | 103,207 | ||
| 2024-04-03 | SMITH IAN F Director | Option exercise · Restricted Stock Units | −3,256 | 9,765 | ||
| 2024-02-13 | Hanrahan Jessie Chief Regulatory Officer | Grant or award · Employee Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2024-02-13 | Hanrahan Jessie Chief Regulatory Officer | Grant or award · Restricted Stock Units | +32,500 | 32,500 | ||
| 2024-02-13 | Cumbo Alexander President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +240,250 | 240,250 | ||
| 2024-02-13 | Cumbo Alexander President and CEO | Grant or award · Restricted Stock Units | +120,125 | 120,125 | ||
| 2024-02-13 | Brooks Gabriel Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +87,500 | 87,500 | ||
| 2024-02-13 | Brooks Gabriel Chief Medical Officer | Grant or award · Restricted Stock Units | +43,750 | 43,750 | ||
| 2024-02-13 | Tan Kevin CFO & Treasurer | Grant or award · Employee Stock Option (Right to Buy) | +85,000 | 85,000 | ||
| 2024-02-13 | Tan Kevin CFO & Treasurer | Grant or award · Restricted Stock Units | +42,500 | 42,500 | ||
| 2024-02-13 | Howton David T Chief Operating Officer | Grant or award · Employee Stock Option (Right to Buy) | +117,500 | 117,500 | ||
| 2024-02-13 | Howton David T Chief Operating Officer | Grant or award · Restricted Stock Units | +58,750 | 58,750 | ||
| 2024-02-13 | Marlowe Jennifer CSO | Grant or award · Employee Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2024-02-13 | Marlowe Jennifer CSO | Grant or award · Restricted Stock Units | +45,000 | 45,000 | ||
| 2024-02-13 | Herzich Paul Chief Technology Officer | Grant or award · Employee Stock Option (Right to Buy) | +57,500 | 57,500 | ||
| 2024-02-13 | Herzich Paul Chief Technology Officer | Grant or award · Restricted Stock Units | +28,750 | 28,750 | ||
| 2024-02-13 | Ganot Ilan Director | Grant or award · Restricted Stock Units | +19,444 | 19,444 | ||
| 2024-01-29 | Ganot Ilan Director | Sale | −139 | $7.99 | $1K | 8,416 |
| 2024-01-27 | Ganot Ilan Director | Option exercise | +388 | 8,555 |
Page 13 of 21 · 403 trades